About PinCell
PinCell is a company based in Milano (Italy) founded in 2008 by Carlo Pincelli and Alessandra Marconi was acquired by Scinai in March 2025.. PinCell has raised $1.78 million across 1 funding round from investors including Scinai and Sofinnova Partners. PinCell offers products and services including Anti-inflammatory Therapy. PinCell operates in a competitive market with competitors including ASLAN Pharmaceuticals, Concerto Biosciences, UNION Therapeutics, Biosion and Forte Biosciences, among others.
- Headquarter Milano, Italy
- Founders Carlo Pincelli, Alessandra Marconi
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pincell S.R.L.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PinCell
PinCell offers a comprehensive portfolio of products and services, including Anti-inflammatory Therapy. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops therapies targeting skin disease pathways with high unmet needs
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of PinCell
PinCell has successfully raised a total of $1.78M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.78 million completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.8M
-
First Round
First Round
(07 May 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2020 | Amount | Seed - PinCell | Valuation | Sofinnova Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PinCell
PinCell has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Scinai and Sofinnova Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Founded Year | Domain | Location | |
|
Provider of immuno-therapeutics solutions for the healthcare industry
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PinCell
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PinCell
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pincell Comparisons
Competitors of PinCell
PinCell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ASLAN Pharmaceuticals, Concerto Biosciences, UNION Therapeutics, Biosion and Forte Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Targeted small molecules are developed for oncology treatments.
|
|
| domain | founded_year | HQ Location |
Microbe-based products are developed for agriculture and human health.
|
|
| domain | founded_year | HQ Location |
Small molecule antibiotics are developed for bacterial infections.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for inflammatory skin diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pincell
Frequently Asked Questions about PinCell
When was PinCell founded?
PinCell was founded in 2008 and raised its 1st funding round 12 years after it was founded.
Where is PinCell located?
PinCell is headquartered in Milano, Italy.
Is PinCell a funded company?
PinCell is a funded company, having raised a total of $1.78M across 1 funding round to date. The company's 1st funding round was a Seed of $1.78M, raised on May 07, 2020.
What does PinCell do?
Pincell develops anti-inflammatory therapy for the treatment of skin diseases. It provides treatments for different dermatological disorders particularly chronic inflammatory orphan diseases of the skin. They have developed the drug by targeting pathways involved in the pathomechanism.
Who are the top competitors of PinCell?
PinCell's top competitors include ASLAN Pharmaceuticals, Concerto Biosciences and UNION Therapeutics.
What products or services does PinCell offer?
PinCell offers Anti-inflammatory Therapy.
Who are PinCell's investors?
PinCell has 2 investors. Key investors include Scinai, and Sofinnova Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.